Source:http://linkedlifedata.com/resource/pubmed/id/10891115
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
13
|
pubmed:dateCreated |
2000-7-27
|
pubmed:abstractText |
Prodigiosins (Ps) represent a family of naturally occurring red pigments characterized by a common pyrrolylpyrromethene skeleton. Some members of this family have been shown to possess interesting immunosuppressive properties exerted with a novel mechanism of action, different from that of currently used drugs. In fact, Ps inhibit phosphorylation and activation of JAK-3, a cytoplasmic tyrosine kinase associated with a cell surface receptor component called common gamma-chain, which is exclusive of all IL-2 cytokine family receptors. Blocking common gamma-chain transduction activity results in a potent and specific immunosuppressive activity. With respect to the interesting and unexploited immunomodulating properties of this family of compounds we initiated a medicinal chemistry program aimed at finding novel prodigiosin derivatives with improved immunosuppressive activity and lower toxicity. Utilizing an unprecedented and flexible way of assembling the prodigiosin frame, a number of new derivatives have been prepared and tested leading to the choice of 4-benzyloxy-5-[(5-undecyl-2H-pyrrol-2-ylidene)methyl]-2, 2'-bi-1H-pyrrole (PNU-156804, 16) as a lead immunosuppressant.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:BargiottiAA,
pubmed-author:CarliniOO,
pubmed-author:ColottaFF,
pubmed-author:D'AlessioRR,
pubmed-author:FerrariMM,
pubmed-author:GnocchiPP,
pubmed-author:IsettaAA,
pubmed-author:MongelliNN,
pubmed-author:MottaPP,
pubmed-author:RossiAA,
pubmed-author:RossiMM,
pubmed-author:TibollaMM,
pubmed-author:VanottiEE
|
pubmed:issnType |
Print
|
pubmed:day |
29
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2557-65
|
pubmed:dateRevised |
2008-7-16
|
pubmed:meshHeading |
pubmed-meshheading:10891115-Animals,
pubmed-meshheading:10891115-Cell Survival,
pubmed-meshheading:10891115-Female,
pubmed-meshheading:10891115-Humans,
pubmed-meshheading:10891115-Hypersensitivity, Delayed,
pubmed-meshheading:10891115-Immunosuppressive Agents,
pubmed-meshheading:10891115-Lymphocytes,
pubmed-meshheading:10891115-Mice,
pubmed-meshheading:10891115-Mice, Inbred C57BL,
pubmed-meshheading:10891115-Prodigiosin,
pubmed-meshheading:10891115-Pyrroles,
pubmed-meshheading:10891115-Spleen,
pubmed-meshheading:10891115-Structure-Activity Relationship,
pubmed-meshheading:10891115-Tumor Cells, Cultured
|
pubmed:year |
2000
|
pubmed:articleTitle |
Synthesis and immunosuppressive activity of novel prodigiosin derivatives.
|
pubmed:affiliation |
Departments of Chemistry and Pharmacology, Discovery Research Oncology, Pharmacia & Upjohn SpA, Nerviano (MI), Italy. roberto.dalessio@eu.pnu.com
|
pubmed:publicationType |
Journal Article,
In Vitro
|